高级检索
    欧阳取长, 胡哲煜, 朱文珍. Ⅱ~Ⅳ期乳腺癌患者中Panagen激活继发性免疫反应和白细胞活性的Ⅱ期多中心双盲安慰剂对照临床研究[J]. 循证医学, 2018, 18(3): 140-143. DOI: 10.12019/j.issn.1671-5144.2018.03.004
    引用本文: 欧阳取长, 胡哲煜, 朱文珍. Ⅱ~Ⅳ期乳腺癌患者中Panagen激活继发性免疫反应和白细胞活性的Ⅱ期多中心双盲安慰剂对照临床研究[J]. 循证医学, 2018, 18(3): 140-143. DOI: 10.12019/j.issn.1671-5144.2018.03.004
    shu
    OUYANG Qu-chang, HU Zhe-yu, ZHU Wen-zhen. Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 140-143. DOI: 10.12019/j.issn.1671-5144.2018.03.004
    Citation: OUYANG Qu-chang, HU Zhe-yu, ZHU Wen-zhen. Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 140-143. DOI: 10.12019/j.issn.1671-5144.2018.03.004
    shu

    Ⅱ~Ⅳ期乳腺癌患者中Panagen激活继发性免疫反应和白细胞活性的Ⅱ期多中心双盲安慰剂对照临床研究

    Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回